All In Biotech

Free tool

FAERS Monitor: Heparin Sodium

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 017007 or its brand name (Heparin Sodium, Heparin Sodium). Reports on generic versions are filed under their own applications.

Reports

14,058

Serious

11,053

79% of reports

Hospitalization

5,586

Death reported

2,653

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • heparin-induced thrombocytopenia1,293
  • drug ineffective1,043
  • off label use787
  • nausea754
  • drug hypersensitivity643
  • vomiting620
  • hypotension571
  • dyspnoea558
  • pulmonary embolism519
  • sepsis503
  • pyrexia499
  • anaemia488
  • abdominal pain483
  • thrombocytopenia479
  • thrombosis458

Reports by year received

View as table
YearReports
2004464
2005225
2006189
2007127
20081,029
2009247
2010472
2011403
2012356
2013329
2014276
2015367
2016402
2017527
2018642
2019796
2020705
2021975
20221,141
20231,251
20241,027
2025998
20261,110

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,101 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
heparin-induced thrombocytopeniaSignal1,293531.8500.2505,159
thrombosisSignal4588.67.83,044
pulmonary embolismSignal5198.27.53,276
sepsisSignal5036.86.22,471
thrombocytopeniaSignal4796.45.92,194
drug hypersensitivitySignal6435.04.62,056
hypotensionSignal5714.33.91,435
anaemiaSignal4883.83.51,027
abdominal painSignal4833.12.8696
pyrexiaSignal4992.22.0314
vomiting6202.01.8303
dyspnoea5581.51.487
nausea7541.41.399
off label use7871.31.372
drug ineffective1,0431.21.132

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.